TY - JOUR
T1 - Low central nervous system posaconazole concentrations during cerebral phaeohyphomycosis
AU - Barde, François
AU - Billaud, Eliane
AU - Goldwirt, Lauriane
AU - Horodyckid, Catherine
AU - Jullien, Vincent
AU - Lanternier, Fanny
AU - Lesprit, Philippe
AU - Limousin, Lucie
AU - Cohen, Jérémie F.
AU - Lortholary, Olivier
N1 - Publisher Copyright:
© 2019 American Society for Microbiology. All Rights Reserved.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Posaconazole diffusion has been documented in various organs, which contrasts with the scarce data available for the human central nervous system (CNS). We analyzed posaconazole concentrations in plasma and multiple CNS specimens taken from a patient who received posaconazole because of cerebral phaeohyphomycosis. Low posaconazole concentrations were obtained in CNS specimens, with sample-to-plasma ratios between 5% and 22%. This case highlights the role of neurosurgery during cerebral phaeohyphomycoses, even those caused by posaconazole-susceptible black fungi.
AB - Posaconazole diffusion has been documented in various organs, which contrasts with the scarce data available for the human central nervous system (CNS). We analyzed posaconazole concentrations in plasma and multiple CNS specimens taken from a patient who received posaconazole because of cerebral phaeohyphomycosis. Low posaconazole concentrations were obtained in CNS specimens, with sample-to-plasma ratios between 5% and 22%. This case highlights the role of neurosurgery during cerebral phaeohyphomycoses, even those caused by posaconazole-susceptible black fungi.
KW - Antifungal therapy
KW - Cerebral phaeohyphomycosis
KW - Invasive fungal infections
KW - Plasma drug levels
KW - Rhinocladiella mackenziei
KW - Therapeutic drug monitoring
UR - http://www.scopus.com/inward/record.url?scp=85073765086&partnerID=8YFLogxK
U2 - 10.1128/AAC.01184-19
DO - 10.1128/AAC.01184-19
M3 - Article
C2 - 31427294
AN - SCOPUS:85073765086
SN - 0066-4804
VL - 63
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 11
M1 - e01184-19
ER -